These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 28705706

  • 1. Inflammatory myofibroblastic tumors of the lung carrying a chimeric A2M-ALK gene: report of 2 infantile cases and review of the differential diagnosis of infantile pulmonary lesions.
    Tanaka M, Kohashi K, Kushitani K, Yoshida M, Kurihara S, Kawashima M, Ueda Y, Souzaki R, Kinoshita Y, Oda Y, Takeshima Y, Hiyama E, Taguchi T, Tanaka Y.
    Hum Pathol; 2017 Aug; 66():177-182. PubMed ID: 28705706
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
    Mariño-Enríquez A, Wang WL, Roy A, Lopez-Terrada D, Lazar AJ, Fletcher CD, Coffin CM, Hornick JL.
    Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
    [Abstract] [Full Text] [Related]

  • 5. ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract.
    Fuehrer NE, Keeney GL, Ketterling RP, Knudson RA, Bell DA.
    Arch Pathol Lab Med; 2012 Jun; 136(6):623-6. PubMed ID: 22646268
    [Abstract] [Full Text] [Related]

  • 6. Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype.
    Hisaoka M, Shimajiri S, Matsuki Y, Meis-Kindblom JM, Kindblom LG, Li XQ, Wang J, Hashimoto H.
    Pathol Int; 2003 Jun; 53(6):376-81. PubMed ID: 12787312
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours.
    Yamamoto H, Yoshida A, Taguchi K, Kohashi K, Hatanaka Y, Yamashita A, Mori D, Oda Y.
    Histopathology; 2016 Jul; 69(1):72-83. PubMed ID: 26647767
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel ATIC-ALK fusion mutation: a case report.
    Tateishi Y, Okudela K, Kawai S, Suzuki T, Umeda S, Matsumura M, Kioi M, Ohashi K.
    Diagn Pathol; 2016 Nov 15; 11(1):132. PubMed ID: 27846861
    [Abstract] [Full Text] [Related]

  • 11. Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification.
    Takeuchi K, Soda M, Togashi Y, Sugawara E, Hatano S, Asaka R, Okumura S, Nakagawa K, Mano H, Ishikawa Y.
    Clin Cancer Res; 2011 May 15; 17(10):3341-8. PubMed ID: 21430068
    [Abstract] [Full Text] [Related]

  • 12. Detection of ALK protein expression in lung squamous cell carcinomas by immunohistochemistry.
    Wang J, Shen Q, Shi Q, Yu B, Wang X, Cheng K, Lu G, Zhou X.
    J Exp Clin Cancer Res; 2014 Dec 21; 33(1):109. PubMed ID: 25527865
    [Abstract] [Full Text] [Related]

  • 13. Cytopathologic features of epithelioid inflammatory myofibroblastic sarcoma with correlation of histopathology, immunohistochemistry, and molecular cytogenetic analysis.
    Lee JC, Wu JM, Liau JY, Huang HY, Lo CY, Jan IS, Hornick JL, Qian X.
    Cancer Cytopathol; 2015 Aug 21; 123(8):495-504. PubMed ID: 26139079
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor.
    Ouchi K, Miyachi M, Tsuma Y, Tsuchiya K, Iehara T, Konishi E, Yanagisawa A, Hosoi H.
    Pediatr Blood Cancer; 2015 May 21; 62(5):909-11. PubMed ID: 25682942
    [Abstract] [Full Text] [Related]

  • 16. A novel fusion of HNRNPA1-ALK in inflammatory myofibroblastic tumor of urinary bladder.
    Inamura K, Kobayashi M, Nagano H, Sugiura Y, Ogawa M, Masuda H, Yonese J, Ishikawa Y.
    Hum Pathol; 2017 Nov 21; 69():96-100. PubMed ID: 28504207
    [Abstract] [Full Text] [Related]

  • 17. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor.
    Ma Z, Hill DA, Collins MH, Morris SW, Sumegi J, Zhou M, Zuppan C, Bridge JA.
    Genes Chromosomes Cancer; 2003 May 21; 37(1):98-105. PubMed ID: 12661011
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases.
    Li XQ, Hisaoka M, Shi DR, Zhu XZ, Hashimoto H.
    Hum Pathol; 2004 Jun 21; 35(6):711-21. PubMed ID: 15188137
    [Abstract] [Full Text] [Related]

  • 20. Chromogenic in situ hybridisation (CISH) is a powerful method to detect ALK-positive non-small cell lung carcinomas.
    Wagner F, Streubel A, Roth A, Stephan-Falkenau S, Mairinger T.
    J Clin Pathol; 2014 May 21; 67(5):403-7. PubMed ID: 24293609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.